February 22, 2016May 13, 2016

Leukemia and Lymphoma Patients Achieving Remission in Immunotherapy Trial, Researcher Tells AAAS Meeting

News

Preliminary results from the Fred Hutchinson Cancer Research Center’s ongoing study into an experimental, ‘living’ immunotherapy found that it achieved sustained remission in 27 of 29 patients with advanced blood cancer. The ... Read more

February 17, 2016February 17, 2016

Oncologist Reports ‘Dramatic’ Anti-Cancer Effect Seen in New T-cell Therapy

News

Dr. Stanley Riddell, an oncologist and immunotherapy researcher at the Fred Hutchinson Cancer Research Center in Seattle, recently presented “dramatic” results from his adoptive T-cell strategy to fight cancer at the ... Read more